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Monoclonal Antibodies as Investigative Tools in Onchocerciasis
Niklaus Weiss From the Laboratory oj Immunoparasitology,
Swiss Tropical Institute, Basel, Switzerland
The development of monoclonal antibodies against parasites can facilitate analysis of
host-parasite interactions and can lead to the identification and characterization of anti-
gens that induce protective responses in the immunized host. As diagnostic reagents for
human and bovine onchocerciasis, monoclonal antibodies have been used to detect cir-
culating antigens. So far only complex antigens have been used to generate monoclonal
antibodies against filarial parasites. The use of such heterogeneous immunogens may re-
sult in interference or even in inhibition of the response to the desired parasite antigen(s).
Epitopes that are similar or identical to determinants on host molecules or that are com-
ponents of other infectious agents serve to complicate the generation and selection of
monoclonal antibodies against Onchocerca volvulus antigens, and cross-reactivity can
be due to monoclonal antibodies reacting with phosphorylcholine, which is present in
many preparations of helminth antigens. Because of the host-dependent immunogenicity
of filarial agents, reagents should be screened carefully for species specificity by use of
a set of different helminth antigens. It is hoped that active collaboration among all inves-
tigators engaged in filariasis research will facilitate resolution of such difficulties.
The development of monoclonal antibodies to para-
sites can facilitate analysis of host-parasite interac-
tions and' can lead to the identification and charac-
terization of antigens that induce protective
responses in the immunized host. Progress of this
kind in the field of malaria was recently well
documented [1, 2], and in November 1983, the Sci-
entific Working Group on Filariasis conducted a
filariasis laboratory workshop in Lille, France, from
which it clearly emerged that for filariasis the era
of monoclonal antibodies had just begun [3].
I will restrict this background paper to applica-
tions of monoclonal antibodies in onchocerciasis.
I will include results of published work, data from
the Lille meeting, and observations from unpub-
lished work (M. Gualzata, C. Heusser, and N. Weiss).
Finally, I will discuss briefly some aspects that com-
plicate the generation and selection of monoclonal
antibodies to Onchocerca volvulus and add a list of
potential uses of monoclonal antibodies in relation
to onchocerciasis.
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Generation of Monoclonal Antibodies to
Onchocerca Antigens
At the Lille meeting, 17monoclonal antibodies from
three different laboratories were available. These
monoclonal antibodies had been generated with use
of either adult O. volvulus somatic antigens for im-
munization (two rat monoclonal antibodies from the
Centre d'lmmunologie et de Biologie Parasitaire,
Lille; 12mouse monoclonal antibodies from the Na-
tional Institute for Medical Research, Mill Hill, Lon-
don) or Onchocerca gibsoni eggs and microfilariae
(three mouse monoclonal antibodies from the Walter
and Eliza Hall Institute, Melbourne). The specific-
ity of these monoclonal antibodies was tested by
ELISA with use of 37 different filarial and 10 non-
filarial antigens. Sixteen monoclonal antibodies
reacted with filarial antigens other than those of On-
chocerca. In addition, 12were reactive with Ascaris
lumbricoides adult worm extracts and 10 with Tox-
ocara canis adult worm extracts. Only one mono-
clonal antibody (2E8CI, Mill Hill) seemed to be
genus-specific reacting only with antigens from
O. volvulus, Onchocerca lienalis, and Onchocerca
gutturosa female worms. Some of the above-
mentioned monoclonal antibodies weretested on im-
munoblots; multiple bands with soluble extracts of
0. volvulus and Brugia malayi weredetected, a find-
ing indicating the presence of common antigenic epi-
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Table 1. Reaction patterns of some monoclonal anti-
bodies obtained after fusion of P3 x 63 (Ag 8.653)
myeloma cells with spleen cells of a BALB/c mouse
immunized with Onchocerca volvulus eggs.
Isotype of monoclonal antibodyt
Antigens" I' I' YJ I' I'
Onchocerca volvulus ++ ++ ++ ++ ++
Dipetalonema viteae
(female) ++ + ++ ++ ++
D. viteae (male) + ++ ++ +
Brugia malayi + + ++ +
Ascaris suum + ++ ++ ++
Toxocara canis (larvae)
Schistosoma mansoni
Fasciola hepatica +
Echinococcus (hydatid) +
Phosphorylcholine-BSA + +
NOTE. A micro-ELISA system was used to assay antibody.
Antigens were coated onto microtiter wells at a protein concen-
tration of 1-5 I'g/ml. Cell culture supernatant was added to
washed plates and incubated for 30 min at 37°C. Plates were
then washed and incubated for 30 min at 37°C with goat an-
timouse IgG, IgA, or IgM antiserum labeled with horseradish
peroxidase (adsorbed with human serum: Kirkegaard-Perry
14,18-07, Gaithersburg, Md.). Enzyme substrate was added and
the color generated was measured at 492 nm wave length.
* All antigen preparations were PBS extracts of adult worms,
except those of T. canis (excretory/secretory products of lar-
vae) and of Echinococcus (hydatid fluid).
t Determinations of isotype and antiphosphorylcholine activity
were performed by M. Gualzata at the laboratory of Dr. C.
Heusser (Ciby-Geigy, Basel). Values indicated as + +, +, and
- correspond to OD values of 1.0, 0.2-1.0, and 0.2, respectively.
topes on different molecules in the crude parasite
extracts.
At the Swiss Tropical Institute in Basel, we per-
formed four fusion experiments in 1983with the aim
of generating monoclonal antibodies to infective lar-
vae of O. volvulus. In a collaboration with the On-
chocerciasis Control Programme (Drs. M. Karam
and S. Meredith), weinjected four BALB/c mice with
50-80 living larvae harvested from blackflies that had
fed on infected human volunteers. In contrast to the
response of mice in experiments in which Dipeta-
lonema viteae larvae were used, in these mice the re-
sponse to infective larvae was very weak, and no
monoclonal antibodies with antisurface or antiso-
matic activity could be isolated.
Early in 1984 we used an immunization scheme
similar to that described by Dr. Karen Forsyth [7];
mice were immunized repeatedly with eggs of O. vol-
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vulus (one ip and three iv injections; 104 eggs per
injection). In a first fusion experiment, 12 mono-
clonal antibodies were detected with use of an adult
O. volvulus antigen in ELISA. Twomonoclonal an-
tibodies reacting with a battery of other helminth
antigens and to human serum were not recloned. The
reaction patterns of five recloned monoclonal anti-
bodies to filarial and other antigens are summarized
in table 1.All of these monoclonal antibodies reacted
with O. volvulus egg membranes and recognized an-
tigens on the egg and the uterus membranes when
tested by immunofluorescent assay (IFA) on frozen
sections of D. viteae female worms. None of the
monoclonal antibodies were specific for O. volvu-
lus antigen(s). All the monoclonal antibodies reacted
with numerous bands on Western blots of a crude
antigen extract of adult O. volvulus. It has recently
been shown that all of the monoclonal antibodies
to B. malayi except those that recognized stage-
specific antigens react with multiple bands on West-
ern blots [4].
Monoclonal Antibodies as Diagnostic
Reagents for Onchocerciasis
So far, application of monoclonal antibodies to on-·
chocerca antigens has been restricted to the detec-
tion of circulating antigens associated with human
[5, 6] and bovine [7] onchocerciasis. Table 2 lists the
monoclonal antibodies used either in a radioimmuno-
precipitation polyethylene glycol assay (RIPEGA)
or in an immunoradiometric assay (IRMA). With
both test systems, antigen detection was possible in
70010-80010 of microfilaria-positive individuals.
Merits and limitations of the two tests were evalu-
ated and discussed at the Lille meeting [3]. Host an-
tibodies seem to interfere in both assays. In two
studies [5, 6] the prevalence of circulating antigen
was highest in children younger than 10 years old.
In this age group titers of IgG antibody to O. volvu-
lus are significantly lower than in other age groups.
False-positive results due to autoantibodies havebeen
observed in the RIPEGA [8], and rheumatoid fac-
tors have been found in patients with onchocercia-
sis [9]. Preliminary experiments conducted at the
Lille meeting suggest that it might be possible to
eliminate false-positive results by treating sera with
acid prior to testing [3]. Acid pretreatment of sera
is possible because all three monoclonal antibodies
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Table 2. Monoclonal antibodies used for antigen detection in human and bovine onchocerciasis and bancroftian
filariasis.
Monoclonal antibody Reference Immunization Target antigen Assay
IA2.23 (rat) 5 Onchocerca volvulus somatic "Microfilaria egg cuticle" (TCA RIPEGA
antigen/FCA soluble)
GIB 13 (BALB/c) 6 Onchocerca gibsoni eggs Egg membrane (TCA soluble, heat IRMA
GIB 86/85 (BALB/c) 7 and pronase resistant)
NOTE. All four monoclonal antibodies had similar reaction patterns when tested against different helminth antigens in ELISA
(Lille workshop). Cross-reactivity was observed with antigens from Onchocerca gutturosa, Onchocerca lienalis, Brugia malayi,
Brugia pahangi, Litomosoides carinii, Dipetalonema viteae, and Ascaris lumbricoides. In addition, GIB 13 reacted with hydatid
fluid. Abbreviations: FCA = Freund's complete adjuvant; TCA = trichloroacetic acid; RIPEGA = radioimmunoprecipitation
polyethylene glycol assay; and IRMA = immunoradiometric assay.
recognize trichloroacetic acid-soluble circulating
antigens.
Complications of Generating and Selecting
Monoclonal Antibodies to O. volvulus Antigens
So far, only very complex antigens, such as various
extracts or intact organisms at different life-cycle
stages, have been used to generate monoclonal anti-
bodies to filarial parasites. With such heterogeneous
immunogens, the immune response to certain dom-
inant epitopes can interfere or even inhibit the re-
sponse to the desired parasite antigen(s). In addition,
complex antigens may contain epitopes that are simi-
lar or identical to determinants on host molecules
or that are components of other infectious agents.
As an example, molecules bearing phosphorylcho-
line (PC) werefound in bacteria, fungi, and dermato-
phytes as well as in several helminth parasite species
(nematodes, trematodes, and cestodes).
Several investigators have found elevated levelsof
antibody to PC in mouse sera after injection of the
animals with nematode larvae.PC-bearing molecules
were demonstrated in extracts of adult worms, lar-
vae, and eggs of Toxocara canisbut not in excretory-
secretory products of larvae [10]. The immunization
of mice with 0. volvulus eggs has generated mono-
clonal antibodies with anti-PC reactivity (table 1).
It is therefore not surprising that monoclonal anti-
bodies with such reactivity are not O. volvulus spe-
cific and that they demonstrate cross-reactivity with
antigens derived from other filariae or from non-
filarial helminths. Anti-PC monoclonal antibody
(kindly supplied by Dr. C. Heusser, Ciba-Geigy,
Basel) react with egg and uterus membranes in IFA
as wellas with many bands of a crude extract of adult
O. volvulus on immunoblots. Moreover, it has been
shown that PC conjugated to a carrier can inhibit
the immune response to a hapten attached to the
same molecule [11]. These authors suggested that
PC-bearing parasite molecules could induce a state
of selective tolerance to parasite antigens. We can
conclude, therefore, that choosing an "appropriate"
antigen is extremely difficult and that generated
monoclonal antibodies must be carefully screened
for epitope recognition.
Host-dependent immunogenicity of filarial anti-
gens is another aspect to be considered. For exam-
ple, the immune response to surface antigens is
clearly host-dependent; mice but not hamsters recog-
nize the surface of D. viteaelarvae [12]. Serum anti-
bodies to a major surface component (20,000 dal-
tons) of adult O. volvulus have been demonstrated
in humans with onchocerciasis [13], but several at-
tempts to generate monoclonal antibodies in mice
with use of this purified surface antigen for immu-
nization have failed (Dr. R. M. E. Parkhouse, per-
sonal communication). It might be interestingto pro-
duce human monoclonal antibodies to O. volvulus
antigens with use of peripheral blood lymphocytes
from infected patients; monoclonal antibodies may
be produced that are directed against major serologic
antigens recognized by the natural host. However,
a parasite component that is highly immunogenic
in the mouse may be weaklyimmunogenic in the nat-
ural host. Monoclonal antibodies to such antigens
eventually could be used for detection of antigen in
the serum or urine of infected individuals.
The selection of monoclonal antibodies, especially
after immunization with complex antigens, is of cru-
cial importance and must be matched with specific
requirements. For diagnostic applications, mono-
clonal antibodies should recognize O. volvulus-spe-
cific epitopes of low (in antigen-detection assays) or
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* See goals for "detection of infected individuals."
Table 3. Potential uses of monoclonal antibodies in
onchocerciasis.
Potential Uses of Monoclonal Antibodies
in Onchocerciasis
There is a wide range of applications for monoclonal
antibodies in immunoparasitologic research and in
diagnosis of parasitic diseases [15].Table 3 summa-
rizes the potential uses of monoclonal antibodies and
lists specific goals related to their use in onchocerci-
asis. This list is likely to be incomplete. Achievement
of each goal will require intensive work and substan-
tial funding; it is my opinion that success in over-
coming the difficulties involved can best be facili-
tated by a concentration of efforts in filariasis
research. It is our task to stimulate collaboration
among investigators actively engaged in filariasis re-
search.
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Detection of Onchocerca
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Analysis of antibody-
mediated effector
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Targeting of anti parasite
drugs
high (in competitive immunoassays) immunogenic-
ity, Since no specific antigen probe is available, the
screening of monoclonal antibodies must include a
battery of carefully selected helminth antigens.
Monoclonal antibodies should be screened not only
against parasite extracts but also against metabolic
and surface antigens, which are potential targets for
protective immune responses. When analyzing
monoclonal antibodies for antiparasite activity, one
should bear in mind that antibody-dependent cell-
mediated cytotoxicity reactions may be restricted to
certain isotypes; i.e., the clearance of D. viteae
microfilariae in mice is mediated by IgM but not by
IgG antibodies [14].
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